Rapid kinetics of serum IgA after vaccination with Prevnar®13 followed by Pneumovax®23
Streptococcus pneumoniae is a causative agent of community-acquired pneumonias. The recommendations of the 2012 Advisory Committee on Immunization Practices include vaccination with Prevnar®13 (protein-polysaccharide conjugate vaccine; PCV), followed by Pneumovax®23 (polysaccharide-based vaccine; PS...
Main Authors: | Rebecca R. Crowther, Christine M. Collins, Cheryl Conley, Osvaldo J. Lopez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844017303109 |
Similar Items
-
Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older
by: Ulrike K. Buchwald, et al.
Published: (2021-08-01) -
TNFRSF13B polymorphisms counter microbial adaptation to enteric IgA
by: Jeffrey L. Platt, et al.
Published: (2021-07-01) -
Secretory IgA in breast milk protects against asthma through modulation of the gut microbiota
by: Katherine Donald, et al.
Published: (2024-10-01) -
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis–associated bacteria rather than lactobacilli
by: Eric Armstrong, et al.
Published: (2022-03-01) -
Enzyme linked immunosorbent assay (ELISA) for the detection of IgG, IgM, IgE and IgA against Cysticercus cellulosae in cerebrospinal fluid of patients with neurocysticercosis
by: Odashima Newton Satoru, et al.
Published: (2002-01-01)